DBV Technologies (DBVT)

Currency in USD
13.630
-0.230(-1.66%)
Closed·
13.6300.000(0.00%)
·

DBVT Earnings

Latest Release
Apr 30, 2026
EPS / Forecast
-0.11 / --
Revenue / Forecast
900K / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/03-0.110/--900.00K/------Free Sign Up
2025/12-0.240/--645.00K/------Free Sign Up
2025/09-0.240/--2.77M/------Free Sign Up
2025/06-0.310/--1.47M/------Free Sign Up
2025/03-0.260/--753.00K/------Free Sign Up
2024/12-0.230/-0.227511.00K/2.44M-1.46%-79.06%Free Sign Up
2024/06--/-0.190--/2.31M----Free Sign Up
2024/03-0.280/-0.2301.40M/2.60M-21.74%-46.15%Free Sign Up
2023/12-0.120/-0.1358.87M/8.85M+11.11%+0.23%Free Sign Up
2023/09-0.170/-0.2372.40M/1.30M+28.18%+84.62%Free Sign Up

All numbers in USD

DBV Technologies Earnings Call Summary for Q2/2026

  • DBV Technologies remains on track to file its Viaskin Peanut patch BLA with FDA in Q3 2026, requesting priority review; stock fell 5.4% despite progress.
  • Company funded through Q3 2027 but burns $151.5M annually; market cap stands at $949.6M with InvestingPro rating financial health as 'weak.'
  • FDA has not requested additional data for filing; management completing final CMC discussions and biostatistics formatting before submission.
  • Supplemental BLA for toddlers (ages 1-3) planned by end-2026; Phase II THRIVE study launched in infants (6-12 months) to expand market reach.
  • Commercial infrastructure buildout underway including market access, field force planning, and manufacturing capacity review ahead of potential 2027 launch.
Last Updated: 2026-07-16, 06:06 p/m
Read Full Transcript

FAQ

What Is DBV Technologies's Earnings Per Share (TTM)?

The DBV Technologies EPS (TTM) is -0.601.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.